Current Models to Study the Sporothrix-Host Interaction
- PMID: 37746241
- PMCID: PMC10512367
- DOI: 10.3389/ffunb.2022.833111
Current Models to Study the Sporothrix-Host Interaction
Abstract
Sporotrichosis is a worldwide distributed subcutaneous mycosis that affects mammals, including human beings. The infection is caused by members of the Sporothrix pathogenic clade, which includes Sporothrix schenckii, Sporothrix brasiliensis, and Sporothrix globosa. The fungus can be acquired through traumatic inoculation of conidia growing in vegetal debris or by zoonotic transmission from sick animals. Although is not considered a life-threatening disease, it is an emergent health problem that affects mostly immunocompromised patients. The sporotrichosis causative agents differ in their virulence, host range, and sensitivity to antifungal drugs; therefore, it is relevant to understand the molecular bases of their pathogenesis, interaction with immune effectors, and mechanisms to acquired resistance to antifungal compounds. Murine models are considered the gold standard to address these questions; however, some alternative hosts offer numerous advantages over mammalian models, such as invertebrates like Galleria mellonella and Tenebrio molitor, or ex vivo models, which are useful tools to approach questions beyond virulence, without the ethical or budgetary features associated with the use of animal models. In this review, we analyze the different models currently used to study the host-Sporothrix interaction.
Keywords: animal model; antifungal drugs; ex vivo model; immune response; invertebrate model; pathogen-host interaction; virulence factors.
Copyright © 2022 Vargas-Macías, Gómez-Gaviria, García-Carnero and Mora-Montes.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Analysis of Sporothrix schenckii sensu stricto and Sporothrix brasiliensis virulence in Galleria mellonella.J Microbiol Methods. 2016 Mar;122:73-7. doi: 10.1016/j.mimet.2016.01.014. Epub 2016 Jan 28. J Microbiol Methods. 2016. PMID: 26826293
-
Biological and Clinical Attributes of Sporothrix globosa, a Causative Agent of Sporotrichosis.Infect Drug Resist. 2022 Apr 22;15:2067-2090. doi: 10.2147/IDR.S362099. eCollection 2022. Infect Drug Resist. 2022. PMID: 35498634 Free PMC article. Review.
-
Tenebrio molitor as an Alternative Model to Analyze the Sporothrix Species Virulence.Infect Drug Resist. 2021 Jun 3;14:2059-2072. doi: 10.2147/IDR.S312553. eCollection 2021. Infect Drug Resist. 2021. PMID: 34113132 Free PMC article.
-
Exploring virulence and immunogenicity in the emerging pathogen Sporothrix brasiliensis.PLoS Negl Trop Dis. 2017 Aug 30;11(8):e0005903. doi: 10.1371/journal.pntd.0005903. eCollection 2017 Aug. PLoS Negl Trop Dis. 2017. PMID: 28854184 Free PMC article.
-
Current Progress in Sporothrix brasiliensis Basic Aspects.J Fungi (Basel). 2023 Apr 29;9(5):533. doi: 10.3390/jof9050533. J Fungi (Basel). 2023. PMID: 37233242 Free PMC article. Review.
Cited by
-
Differential Recognition of Sporothrix schenckii, Sporothrix brasiliensis, and Sporothrix globosa by Human Monocyte-Derived Macrophages and Dendritic Cells.Infect Drug Resist. 2023 Jul 25;16:4817-4834. doi: 10.2147/IDR.S419629. eCollection 2023. Infect Drug Resist. 2023. PMID: 37520448 Free PMC article.
-
Therapeutic alternatives for sporotrichosis induced by wild-type and non-wild-type Sporothrix schenckii through in vitro and in vivo assessment of enilconazole, isavuconazole, posaconazole, and terbinafine.Sci Rep. 2025 Jan 25;15(1):3230. doi: 10.1038/s41598-025-87711-3. Sci Rep. 2025. PMID: 39863777 Free PMC article.
-
Development of a Versatile Toolbox for Genetic Manipulation of Sporothrix brasiliensis.Microbiol Spectr. 2023 Feb 27;11(2):e0456422. doi: 10.1128/spectrum.04564-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36847570 Free PMC article.
-
Differential Recognition of Clinically Relevant Sporothrix Species by Human Mononuclear Cells.J Fungi (Basel). 2023 Apr 6;9(4):448. doi: 10.3390/jof9040448. J Fungi (Basel). 2023. PMID: 37108903 Free PMC article.
References
-
- Alegranci P., de Abreu Ribeiro L. C., Ferreira L. S., Negrini Tde C., Maia D. C., Tansini A., et al. (2013). The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii. Mycopathologia 176, 57–65. 10.1007/s11046-013-9663-y - DOI - PubMed
-
- Almeida-Paes R., de Oliveira L. C., Oliveira M. M. E., Gutierrez-Galhardo M. C., Nosanchuk J. D., Zancopé-Oliveira R. M. (2015). Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Biomed. Res. Int. 2015, 212308–212308. 10.1155/2015/212308 - DOI - PMC - PubMed
-
- Almeida-Paes R., Frases S., Araújo G. d. S., de Oliveira M. M. E., Gerfen G. J., Nosanchuk J.D., et al. (2012). Biosynthesis and functions of a melanoid pigment produced by species of the Sporothrix complex in the presence of L-tyrosine. Appl. Environ. Microbiol. 78, 8623–8630. 10.1128/AEM.02414-12 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources